Cargando…
DNA methylation biomarkers for hepatocellular carcinoma
BACKGROUND: Aberrant methylation of DNA is a key driver of hepatocellular carcinoma (HCC). In this study, we sought to integrate four cohorts profile datasets to identify such abnormally methylated genes and pathways associated with HCC. METHODS: To this end, we downloaded microarray datasets examin...
Autores principales: | Fan, Guorun, Tu, Yaqin, Chen, Cai, Sun, Haiying, Wan, Chidan, Cai, Xiong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6142709/ https://www.ncbi.nlm.nih.gov/pubmed/30245591 http://dx.doi.org/10.1186/s12935-018-0629-5 |
Ejemplares similares
-
The expression profiles and prognostic values of HSPs family members in Head and neck cancer
por: Fan, Guorun, et al.
Publicado: (2020) -
Identification of candidate aberrantly methylated and differentially expressed genes in thyroid cancer
por: Tu, Yaqin, et al.
Publicado: (2018) -
Endoplasmic reticulum stress is involved in spiral ganglion neuron apoptosis following chronic kanamycin-induced deafness
por: Tu, Yaqin, et al.
Publicado: (2019) -
Prognostic biomarker SMARCC1 and its association with immune infiltrates in hepatocellular carcinoma
por: Cai, Xiaopeng, et al.
Publicado: (2021) -
DNA methylation biomarkers for nasopharyngeal carcinoma
por: Han, Baoai, et al.
Publicado: (2020)